Effect of Chemotherapeutics and Tocopherols on MCF-7 Breast Adenocarcinoma and KGN Ovarian Carcinoma Cell Lines In Vitro

dc.contributor.author Figueroa Gonzalez, Daniela en_US
dc.contributor.author Asaduzzaman, Mohammad en_US
dc.contributor.author Young, Fiona Margaret en_US
dc.date.accessioned 2019-06-27T01:38:40Z
dc.date.available 2019-06-27T01:38:40Z
dc.date.issued 2019-01-15
dc.date.updated 2019-05-19T07:05:18Z
dc.description Copyright © 2019 Daniela Figueroa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. en_US
dc.description.abstract The combination of doxorubicin and cyclophosphamide commonly used to treat breast cancer can cause premature ovarian failure and infertility. α-Tocopherol is a potent antioxidant whereas γ-tocopherol causes apoptosis in a variety of cancer models in vitro including breast cancer. We hypothesised that the combination of doxorubicin (Dox) and 4-hydroperoxycyclophosphamide (4-Cyc) would be more cytotoxic in vitro than each agent alone, and that α-tocopherol would reduce and γ-tocopherol would augment the cytotoxicity of the combined chemotherapeutics. Human MCF-7 breast cancer and KGN ovarian cells were exposed to Dox, 4-Cyc, combined Dox and 4-Cyc, α-tocopherol, γ-tocopherol, or a combination of Dox and 4-Cyc with α-tocopherol or γ–tocopherol. Cell viability was assessed using a crystal violet assay according to four schedules: 24h exposure, 24h exposure + 24h culture in medium, 24h exposure + 48h culture in medium, or 72h continuous exposure. Supernatants from each separate KGN culture experiment (n=3) were examined using an estradiol ELISA. Dox was cytotoxic to both MCF-7 and KGN cells, but 4-Cyc only killed MCF-7 cells. γ-Tocopherol significantly decreased MCF-7 but not KGN cell viability. The combined chemotherapeutics and γ-tocopherol were more cytotoxic to MCF-7 than KGN cells, and α-tocopherol reduced the cytotoxicity of the combined chemotherapeutics towards KGN ovarian cells, but not MCF-7 cells. The addition of both γ-tocopherol and α-tocopherol to the chemotherapeutic combination of Dox and cyclophosphamide has the potential to increase in vitro chemotherapeutic efficacy against breast cancer cells whilst decreasing cytotoxicity towards ovarian granulosa cells. en_US
dc.description.version Peer Reviewed
dc.identifier.citation Figueroa, D., Asaduzzaman, M., & Young, F. (2019). Effect of Chemotherapeutics and Tocopherols on MCF-7 Breast Adenocarcinoma and KGN Ovarian Carcinoma Cell Lines In Vitro. BioMed Research International, 2019, 1–13. https://doi.org/10.1155/2019/6146972 en_US
dc.identifier.doi https://doi.org/10.1155/2019/6146972 en_US
dc.identifier.issn 2314-6133
dc.identifier.uri http://hdl.handle.net/2328/39243
dc.language.iso en en_US
dc.language.rfc3066 en
dc.publisher Hindawi en_US
dc.rights Copyright © 2019 Daniela Figueroa et al. en_US
dc.rights.holder Daniela Figueroa et al. en_US
dc.title Effect of Chemotherapeutics and Tocopherols on MCF-7 Breast Adenocarcinoma and KGN Ovarian Carcinoma Cell Lines In Vitro en_US
dc.type Article en_US
local.contributor.authorOrcidLookup Figueroa Gonzalez, Daniela: https://orcid.org/0000-0001-7317-7622 en_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
BMRI.2019.6146972.pdf
Size:
1.65 MB
Format:
Adobe Portable Document Format
Description:
Published version
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.84 KB
Format:
Item-specific license agreed upon to submission
Description: